{"id":"https://openalex.org/W23225074","doi":"https://doi.org/10.33588/rn.4603.2007382","title":"Mortalidad en pacientes con enfermedad de Alzheimer tratados con neurol\u00e9pticos at\u00edpicos","display_name":"Mortalidad en pacientes con enfermedad de Alzheimer tratados con neurol\u00e9pticos at\u00edpicos","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W23225074","doi":"https://doi.org/10.33588/rn.4603.2007382","mag":"23225074","pmid":"https://pubmed.ncbi.nlm.nih.gov/18297617"},"language":"es","primary_location":{"id":"doi:10.33588/rn.4603.2007382","doi":"https://doi.org/10.33588/rn.4603.2007382","is_oa":false,"landing_page_url":"https://doi.org/10.33588/rn.4603.2007382","pdf_url":null,"source":{"id":"https://openalex.org/S184263677","display_name":"Revista de Neurolog\u00eda","issn_l":"0210-0010","issn":["0210-0010","1576-6578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322632785","host_organization_name":"Viguera Publishers","host_organization_lineage":["https://openalex.org/P4322632785"],"host_organization_lineage_names":["Viguera Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista de Neurolog\u00eda","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038802405","display_name":"Joan Vilalta Franch","orcid":"https://orcid.org/0000-0002-5306-437X","observed_orcids":["https://orcid.org/0000-0002-5306-437X"]},"institutions":[{"id":"https://openalex.org/I4210121211","display_name":"Hospital Santa Caterina","ror":"https://ror.org/036dkm174","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210121211"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Joan Vilalta Franch","raw_affiliation_strings":["Unitat de Recerca, Hospital de Santa Caterina, Institut d'Assistencia Sanitaria, Salt, Espana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unitat de Recerca, Hospital de Santa Caterina, Institut d'Assistencia Sanitaria, Salt, Espana","institution_ids":["https://openalex.org/I4210121211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012336996","display_name":"Secundino L\u00f3pez Pousa","orcid":"https://orcid.org/0000-0002-2818-3473","observed_orcids":["https://orcid.org/0000-0002-2818-3473"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Secundino L\u00f3pez Pousa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051947155","display_name":"Josep Garre\u2010Olmo","orcid":"https://orcid.org/0000-0002-7817-0814","observed_orcids":["https://orcid.org/0000-0002-7817-0814"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josep Garre Olmo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086704325","display_name":"Antoni Turon Estrada","orcid":"https://orcid.org/0000-0003-3784-7435","observed_orcids":["https://orcid.org/0000-0003-3784-7435"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antoni Turon Estrada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5064501038","display_name":"Imma Pericot Nierga","orcid":"https://orcid.org/0000-0003-0621-4264","observed_orcids":["https://orcid.org/0000-0003-0621-4264"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Imma Pericot Nierga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6109,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.69932081,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"46","issue":"03","first_page":"129","last_page":"129"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9860000014305115},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.7099999785423279},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9399999976158142},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9430000185966492},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.8899999856948853},{"id":"https://openalex.org/keywords/heart-disease","display_name":"heart disease","score":0.949999988079071},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/memantine","display_name":"memantine","score":1.0},{"id":"https://openalex.org/keywords/dementia","display_name":"dementia","score":0.6769999861717224},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5410000085830688},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.47699999809265137},{"id":"https://openalex.org/keywords/relative-risk","display_name":"relative risk","score":0.4390000104904175},{"id":"https://openalex.org/keywords/global-deterioration-scale","display_name":"Global Deterioration Scale","score":0.6600000262260437},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5460000038146973},{"id":"https://openalex.org/keywords/anticholinergic-burden","display_name":"anticholinergic burden","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.8619222640991211},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8454235792160034},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.751913845539093},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5982984304428101},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5651480555534363},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.5244622230529785},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2806210219860077},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1691233217716217},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.14669868350028992}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.33588/rn.4603.2007382","doi":"https://doi.org/10.33588/rn.4603.2007382","is_oa":false,"landing_page_url":"https://doi.org/10.33588/rn.4603.2007382","pdf_url":null,"source":{"id":"https://openalex.org/S184263677","display_name":"Revista de Neurolog\u00eda","issn_l":"0210-0010","issn":["0210-0010","1576-6578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322632785","host_organization_name":"Viguera Publishers","host_organization_lineage":["https://openalex.org/P4322632785"],"host_organization_lineage_names":["Viguera Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista de Neurolog\u00eda","raw_type":"journal-article"},{"id":"pmid:18297617","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18297617","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista de neurologia","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3106919049","https://openalex.org/W2026830529","https://openalex.org/W2105925765","https://openalex.org/W2066049056","https://openalex.org/W2802711734","https://openalex.org/W2063645217","https://openalex.org/W2092983150","https://openalex.org/W4283157481","https://openalex.org/W2809201261","https://openalex.org/W2050820261"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"evaluate":[2],"the":[3,42,66,90,147,176,179,185,192,217,239,252,259,270],"influence":[4],"of":[5,12,54,101,124,149,219,226,238,248,261],"metabolic":[6],"syndrome":[7],"(MS)":[8],"and":[9,34,60,73,83,137,160,184,207,229,255],"a":[10,52,224,235],"history":[11,225],"heart":[13,181,227],"disease":[14,23,182,228],"on":[15,175],"increased":[16,271],"mortality":[17,272],"rates":[18],"among":[19],"patients":[20,56,275],"with":[21,29,58,62,81,276,281],"Alzheimer's":[22],"(AD)":[24],"who":[25,35,278],"have":[26],"been":[27,79],"treated":[28,61,80,280],"cholinesterase":[30],"inhibitors":[31],"or":[32,38,283],"memantine":[33],"received":[36,95],"risperidone":[37,82,208,230],"olanzapine":[39,125,195,282],"therapy":[40],"during":[41,89],"time":[43,88,106],"under":[44],"study.":[45],"PATIENTS":[46],"AND":[47],"METHODS:":[48],"Our":[49],"study":[50],"involved":[51],"sample":[53],"751":[55],"diagnosed":[57],"AD":[59],"anti-dementia":[63],"drugs.":[64],"Of":[65],"total":[67],"number,":[68],"10.2%":[69],"(n":[70,75,117],"=":[71,76,118,132,135,141,144,155,158,163,166,199,205,210,214],"77)":[72],"7.7%":[74],"58)":[77],"had":[78,94],"olanzapine,":[84],"respectively,":[85],"at":[86,115],"some":[87],"follow-up.":[91],"Twelve":[92],"(1.6%)":[93],"both":[96,194],"substances":[97],"in":[98,146,191,241,274],"different":[99],"periods":[100],"time.":[102],"RESULTS:":[103],"Mean":[104],"follow-up":[105],"was":[107,126,246],"27.52":[108],"+/-":[109],"12.15":[110],"months.":[111],"Mortality":[112],"rate":[113,273],"stood":[114],"14%":[116],"105).":[119],"The":[120],"mean":[121],"maximum":[122],"dose":[123],"4.3":[127],"mg/day":[128,139],"(standard":[129],"deviation,":[130],"SD":[131],"2.55;":[133],"range":[134,143,157,165],"2.5-15)":[136],"1.36":[138],"(SD":[140,154,162],"0.67;":[142],"0.25-3.5)":[145],"case":[148],"risperidone.":[150,284],"Treatment":[151],"lasted":[152],"519.12":[153],"285.2;":[156],"90-1045)":[159],"481.68":[161],"345.22;":[164],"1-1650)":[167],"days,":[168],"respectively.":[169],"If":[170],"age,":[171],"sex,":[172],"conduct":[173],"disorders":[174,263],"Blessed":[177],"scale,":[178],"cumulative":[180],"index":[183],"global":[186],"deterioration":[187],"scale":[188],"are":[189,279],"included":[190],"model,":[193],"(relative":[196],"risk,":[197],"RR":[198],"8.95;":[200],"confidence":[201],"interval,":[202],"CI":[203,212],"95%":[204,213],"2.856-28.046)":[206],"(RR":[209],"4.526;":[211],"1.816-11.281)":[215],"increase":[216],"risk":[218],"death.":[220],"An":[221],"interaction":[222,250],"between":[223,251],"is":[231],"recorded,":[232],"which":[233],"suggests":[234],"possible":[236],"protection":[237],"drug":[240],"this":[242],"group.":[243],"No":[244],"evidence":[245],"found":[247],"an":[249],"two":[253],"drugs":[254],"MS.":[256],"CONCLUSIONS:":[257],"Neither":[258],"presence":[260],"cardiac":[262],"nor":[264],"MS":[265],"allow":[266],"us":[267],"to":[268],"explain":[269],"dementia":[277]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}